AAJ Capital 3 Corp. Announces Definitive Agreement for | Crypto News

VANCOUVER, BC and DUBAI, UAE, July 16, 2025 /PRNewswire/ — AAJ Capital 3 Corp. (TSXV: AAAJ.P) (“AAJ“), a capital pool company as defined under the policies of the TSX Venture Exchange (“TSXV” or the “Exchange“), is pleased to announce that, further to its press release dated May 19, 2025 (the “LOI Press Release“) and the non-binding letter of intent dated May 11, 2025 with XRP Healthcare M&A Holding Inc. (“XRP“), a corporation organized under the laws of the Abu Dhabi Global Markets (ADGM), it has entered into a share exchange agreement dated July 14, 2025 (the “Definitive Agreement“) in respect of a proposed business combination of AAJ and XRP (the “Proposed Transaction“), which AAJ anticipates will constitute its “Qualifying Transaction” pursuant to Policy 2.4 – Capital Pool Companies of the Exchange (“Policy 2.4“), as such time period is outlined within the insurance policies of the Exchange. AAJ, because it exists upon completion of the Proposed Transaction (the “Resulting Issuer“), will proceed the business of XRP.

Terms of the Proposed Transaction

The Definitive Agreement was negotiated at arm’s size and units out that, amongst different issues, at closing of the Proposed Transaction, AAJ will subject 37,492,460 common shares within the capital of AAJ (the “AAJ Shares“) to every of the shareholders of XRP in exchange for every atypical share held within the capital of XRP (the “XRP Shares“) rounded down to the closest complete quantity, which is anticipated to end in a deemed transaction price of CAD$0.40 per AAJ Share.

There are presently 6,450,000 AAJ Shares issued and excellent with no intention to consolidate or break up such shares in reference to the Proposed Transaction. There are additionally presently 645,000 choices to buy AAJ Shares (the “AAJ Options“) issued and excellent.

There are presently 1,000,000 XRP Shares issued and excellent with no intention to consolidate or break up such shares in reference to the Proposed Transaction. There are no different securities of XRP issued and excellent.

It is anticipated that the Resulting Issuer will change its identify to ” XRP Healthcare M&A Holding Inc. “, or such different identify as could also be decided by XRP in its sole discretion, subject to approval by the shareholders of AAJ (the “AAAJ Shareholders“), the TSXV and every other related regulatory authorities (the “Name Change“).

Pursuant to the Definitive Agreement, the completion of the Proposed Transaction stays subject to sure situations precedent that have to be glad or waived, together with, however not restricted to: (i) tendering of closing deliverables; (ii) requisite Exchange and different regulatory approvals; (iii) requisite approvals of the AAJ Shareholders for the Name Change, reconstitution of the board of administrators and the implementation of an equity incentive plan; (iv) completion of the Private Placement; (v) the preparation of requisite financial statements of XRP; (vii) necessities of sponsorship being met or waived; (viii) no materials hostile change occurring with respect to AAJ or XRP between the date of coming into into the Definitive Agreement and the deadline of the Proposed Transaction; and (ix) the deadline occurring on or earlier than October 31, 2025. If all situations to the completion of the Proposed Transaction are glad or waived, the Proposed Transaction is anticipated to be carried out.

The Proposed Transaction is not going to represent a “Non-Arm’s Length Qualifying Transaction” (within the that means of Policy 2.4 of the Exchange).

After giving impact to the Proposed Transaction, the shareholders of XRP (the “XRP Shareholders“) will collectively train control over the Resulting Issuer. However, as on the date hereof, it isn’t doable for the events to find out the quantity of AAJ Shares that will probably be issued upon completion of the Proposed Transaction nor the possession percentages related to the AAJ Shareholders and the XRP Shareholders instantly previous to the completion of the Proposed Transaction as this may rely on and the Private Placement, such components having an impression on the entire quantity of AAJ Shares that will probably be issued in reference to the Proposed Transaction. Upon the foregoing being decided, AAJ will subject a press release advising of such.

It is meant that the Resulting Issuer will probably be listed on the TSXV as a Tier 2 Industrial/Healthcare Issuer, subject to TSXV approval.

Private Placement

Further to the LOI Press Release, in reference to the Proposed Transaction, AAJ intends to finish a non-public placement of a minimal of  4,450,000 subscription receipts of AAJ  Shares to raise gross proceeds of up a minimal of CAD$1,780,000 (the “Private Placement“) at a price of what is anticipated to be CAD$0.40 per AAJ Share (the “Offering Price“). The proceeds of the Private Placement are meant for use for enlargement of XRP’s fund enlargement, operational scale-up and common company and dealing capital functions.

About AAJ Capital 3 Corp.

AAJ Capital 3 Corp. is integrated underneath the Business Corporations Act (British Columbia) and is a capital pool company within the that means of the insurance policies of the Exchange. AAJ has not commenced operations and has no property different than money. AAJ’s principal business is the identification and analysis of property or companies with a view to finishing a “Qualifying Transaction” underneath Policy 2.4.

About XRP Healthcare M&A Holding Inc.

XRP Healthcare M&A Holding Inc. (“XRP”) is a privately held company integrated in Abu Dhabi, United Arab Emirates, targeted on modernizing healthcare entry throughout rising markets. Through strategic acquisitions and proprietary point-of-care diagnostics, the company operates a growing pharmacy and wholesale distribution community and goals to scale built-in health companies throughout Africa. XRP additionally leverages its AI-powered digital platform, XRPH AI, to boost affected person engagement, ship multilingual healthcare help, and improve health outcomes throughout the areas it serves. The company operates by means of its 90%-owned subsidiary in Uganda.

Following the completion of the Proposed Transaction, the Resulting Issuer will wholly-own XRP Healthcare M&A Holding Inc., whereby the XRP will proceed to control and operate its 90% owned subsidiary Pharma Ville Limited.

A abstract of choose audited financial info of XRP for the 12 months ended June thirtieth, 2024 is included within the desk beneath:

Additional financial info with respect to XRP will probably be supplied within the itemizing assertion to be filed in reference to the Proposed Transaction.

Proposed Directors and Officers

Further to the LOI Press Release, and subject to additional willpower, it’s presently anticipated that each one of the present administrators and officers of AAJ will resign from their respective positions with AAJ in reference to the closing of the Proposed Transaction. Whitney Lynn, Kain Roomes, Laban Roomes, Keith Errey and Joseph Swantack Jr. are anticipated to represent the board of administrators of the Resulting Issuer and it’s nonetheless anticipated Kain Roomes will probably be appointed Chief Executive Officer. Anna Skowron is anticipated to be appointed the Chief Financial Officer of the Resulting Issuer.

Whitney Lynn, Chairman

Retired 1st Lieutenant Whitney Lynn is a proposed Chairman of the Resulting Issuer and a veteran of the US Army Medical Service Corps and a seven-time Ironman Triathlon finisher, (2.4-mile swim, 112-mile bike, 26.2-mile run) brings over 45 years of expertise in M&A, business development, startups, investment, and management. With a confirmed monitor document of attaining measurable outcomes throughout international operations in a number of industries, Whitney is a extremely achieved CEO, entrepreneur, startup mentor, business advisor, and govt turnaround guide.

As a Vice President Software Mergers and Acquisitions at Corum Group Ltd, Whitney was half of the workforce that has created over 10 billion USD in wealth and performed over 400 M&A transactions with over $4 Billion US Dollars in transactions in more than 13 international locations during the previous 35 years. In this capability, he supplied strategic M&A and transactional help and steering to help corporations grow. Whitney additionally served as President of RWBC Holding, the place he supplied help to a family-owned company, serving to to handle its growth. During his tenure as Interim President & CEO of the 300 million USD Borland International, Whitney executed a strategic plan to gain profitability by downsizing headcount and implementing aggressive cost-saving initiatives. He additionally revamped the advertising strategy, accomplished the profitable acquisition of Open Environment Corporation, the place he was Fractional Chief Operating Officer, and drove the profitable integration of OEC workers and subsidiaries with new management and tradition worldwide. As President & Chief Operating Officer of Colorbus, Inc., Whitney led the worldwide consolidation, integration, and restructuring of the mixed corporations with 180 workers and worldwide income of $45M. He lowered bills and headcount to maximise effectivity and income contribution per worker, considerably enhancing high quality, on-time supply, and buyer satisfaction.

He additionally was the Founder, Executive Vice President and Chief Operating Officer at lncat Systems Software USA Inc which was efficiently offered after solely two years to Adaptec Inc for a whole worth of $26 US Million Dollars and the President & CEO of Meridian Data Inc. With a expertise for building and nurturing sturdy, trust-based relationships, Whitney advises, coaches, and mentor’s leaders to speed up growth and profitability whereas positioning corporations for takeover, negotiating mergers or acquisitions, and main restructuring efforts as soon as acquired.

Whitney has based and grown a number of extremely profitable smaller software program, systems, and storage corporations, turning round corporations from unprofitable outlined market segments to income technology by developing focused merchandise, growing buyer base, and market share. He has additionally constructed main key account relationships and channels of distribution.

As a business proprietor, Whitney bought the Ironman bike store in Kona Hawaii, and a high-end Triathlon Specific Bike Store in San Diego, CA. He elevated margins and gross sales by lowering operational bills, managed operations, budgeting, finance, P&L, recruiting and coaching workers, and stock management. Whitney additionally grew the business with aggressive sponsor packages and triathlete endorsements. He is a Member of the Eliances, Newchip Accelerator, the place he has labored with and mentored ideation, early stage and start-up corporations in numerous capacities guiding them in the direction of buying traders and creation of distinctive product launch methods with the simplest channels of distribution. He has elevated margins and gross sales by means of the elimination of redundant operations, managed operations, budgeting, finance, P&L, recruiting and coaching workers, stock management with great sponsorship networks. Further, he graduated from the University of Arizona with a Bachelor’s Degree in Accounting and General Business.

Kain Roomes, Founder & CEO

Kain Roomes, CEO & founder of XRP Healthcare and is the proposed CEO & director of the Resulting Issuer and is, has a distinctive background that mixes athletic drive, business acumen, and a pioneering imaginative and prescient in blockchain healthcare. Originally set for a skilled soccer profession, Kain’s path took an surprising flip when he immediately misplaced ardour for the sport, main him to fitness modelling, the place he represented main manufacturers like Nike and Sports Direct.

In 2018, he made a daring transfer into cryptocurrency by performing on advice from his father Laban Roomes which resulted in them each promoting their luxurious Rolex Submariner watches to fund an initial Bitcoin investment, later diversifying into altcoins like Zilliqa and XRP. Kains’ strategic decisions turned a £7,500 investment into over £2,000,000, marking him as a notable determine within the crypto space.

In September 2022, Kain co-founded XRP Healthcare together with his father, Laban Roomes, launching the primary pharma and healthcare platform on the XRP Ledger. Under his management, the company grew from zero to a valuation of $194 million within three months. Recently, XRP Healthcare has expanded into mergers and acquisitions in East Africa, positioning itself to make a significant impression on the area’s healthcare accessibility. Kain’s journey is a testomony to resilience, imaginative and prescient and the foresight to take calculated risks-transforming challenges into alternatives and building XRP Healthcare into a main drive within the healthcare industry.

Laban Roomes, Co-Founder & COO

Laban Roomes is a COO and Director of XRP and proposed COO and Director of the Resulting Issuer and is a serial entrepreneur who Co-founded XRP together with his son Kain Roomes, the primary Pharma and Healthcare platform to be constructed on the XRP Ledger.

Having had success investing in a medicinal hashish company (Marigold Projects Jamaica) of which 49% was then offered to the Canadian public company giant Aphria for USD$80 million. Laban began investing in Bitcoin in 2018, and since then has made a number of different investments into Blockchain technology corporations reminiscent of XRP, Zilliqa, Centric and XCAD. Laban designed and manufactured an revolutionary transportable plating machine and in October of 2007, Laban pitched his gold-plating technology – and market traction – stay on the hit BBC T.V investment pitching programme ‘Dragon’s Den’ and efficiently acquired funding, in addition to new steering from multi-millionaire Dragon James Caan. After 3 years Laban bought all his shares back from James Caan while remaining business allies to comply with a new imaginative and prescient for the business. Since then, Laban has attended and provided luxurious items in particular person to the Oscars, created luxurious ranges of iPods and that iPhones for a host of celebrities together with Elton John the Beckhams, Floyd Money Mayweather, Usain Bolt, Mark Wahlberg, Clint Eastwood and Will Smith, to say simply a few, to not point out creating an alternative for a whole bunch of people worldwide to work from home utilizing his transportable gold plating technology. The company has additionally launched initiatives and campaigns to raise money by donating a proportion of the company’s luxurious reward gross sales to raise much-needed money for a number of high-profile charities together with the Elton John Aids Foundation (EJAF), The Teenage Cancer TRUST and SOS Children’s Villages.

Laban has additionally gone on to win the Great British Entrepreneur and the coveted Lloyds TSB – FSB Entrepreneur of the 12 months award and now spends his time in Jamaica, Miami, and Dubai the place he has business pursuits.

Anna Skowron, CFO

Anna Skowron is the present CFO of XRP and proposed CFO of the Resulting Issuer and is has over 14 years’ expertise in strategic accounting and financial management, together with serving as chief financial officer, chief accounting officer and in different senior financial govt roles at each home and multi-national public and personal corporations. She additionally has performed a key function in numerous business acquisitions and capital raising initiatives throughout a number of industries. Since 2015, Ms. Skowron has served as principal of Skowron Accounting Professional Corporation, an Advisory firm that makes a speciality of financial reporting, compliance, company governance and business strategy, during which capability she supplies accounting advisory companies. Ms. Skowron holds a Bachelor of Commerce and Finance with specialization in Accounting and Economics from the University of Toronto and have become a member of the Institute of Chartered Accounts of Ontario in 2014. She is licensed as a Chartered Professional Accountant.

Keith Errey, Independent Director (Proposed)

Keith Errey is a proposed unbiased director of the Resulting Issuer and is an skilled technology entrepreneur and govt with a distinguished profession spanning over 4 a long time throughout healthcare, semiconductors, lasers, and technology commercialization. Most just lately, he served because the Co-Founder and CEO of Isansys Lifecare Ltd (2010–2025), the place he led the company to grow to be a international chief in wi-fi affected person monitoring systems.

Prior to that, Keith co-founded Toumaz Technology plc (later Sensium Ltd) in 2000, the place he held the function of Chief Executive Officer till 2010. Under his management, the company developed and commercialized Sensium, a groundbreaking semiconductor chip for wearable medical sensors. He performed a central function in securing seed funding, negotiating IP and equity constructions with Imperial College London, and taking the company public by means of a reverse merger on the AIM London exchange. Keith efficiently negotiated licensing offers valued at over USD 2.5 million with Texas Instruments and Cardinal Health.

Between 1998 and 2004, he based and directed Oxford Synergetics Ltd, a technology switch and management consultancy. His work included business audits for Oxford Brookes University and project management for Oxtek Ltd, together with regulatory approvals and manufacturing rollout. Earlier, Keith served as Sales and Marketing Director at Oxford Lasers Ltd (1989–1998), the place he established worldwide subsidiaries in Japan and Germany, negotiated main technology transfers, and led the company back to profitability. He additionally held engineering and manufacturing management roles at Oxford Lasers from 1982, contributing to key business and product development initiatives.

Keith’s tutorial expertise consists of part-time lecturing at Oxford Brookes University, the place he taught modules in Engineering Management and Operations between 1999 and 2001. He was additionally a Research Assistant on the Department of Physics, University of Oxford (1979–1982), specializing in superior laser systems. Earlier in his profession, he taught high college physics and engineering in Australia and labored as a telecommunications engineer at Telecom Australia (now Telstra).

He holds an MSc by thesis from Oxford University (Linacre College), with analysis in plasma excitation and laser systems, and a BSc in Engineering and Physics from the University of New South Wales. He additionally earned skilled engineering {qualifications} by means of open examination at Telecom Australia. Keith has accomplished govt coaching with the Institute of Directors and at Ashfield Management College.

Keith has secured a number of aggressive grants together with SMART, LINK, and BRITE awards, and was a principal engineer on a project that acquired the Queen’s Award for Technology in 1985. His work has been printed in technical journals and books, and he has delivered quite a few technical lectures in Europe and Japan on laser applied sciences and high-speed imaging. He speaks affordable French and has primary proficiency in Japanese, supported by prolonged time residing and dealing internationally, together with in France and Japan.

Joseph J. Swantack Jr. Independent Director (Proposed)

Joseph J. Swantack Jr. is a proposed unbiased director of the Resulting Issuer, who’s a visionary govt and strategic operator based mostly in Columbus, Ohio, with a confirmed monitor document throughout superior medical technology, aerospace innovation, and large-scale retail management. Since 2016, he has served as CEO of STARK Industries LLC, the place he leads groundbreaking collaborations with NASA researchers to pioneer wi-fi health monitoring applied sciences for high-stakes aerospace environments and future exploration-class missions.

In 2020, following STARK Industries’ acquisition of an unique license from NASA Jet Propulsion Laboratory/Caltech to fabricate and distribute the VITAL ventilator—an emergency machine designed by NASA engineers during the COVID-19 disaster—Mr. Swantack spearheaded the formation and spin-off of Spiritus Medical, Inc. He presently serves as Interim CEO and President, overseeing commercialization of this life-saving innovation. Before his entry into healthtech and aerospace, Mr. Swantack constructed a basis in operational management at The Kroger Company, the most important conventional grocery retailer within the U.S. As Operations Manager, he directed store efficiency throughout 250+ areas, managing over $40 million USD in annual budgets all through the Midwest. Blending deep expertise in rising applied sciences with enterprise-scale operational experience, Joseph Swantack is driving impression on the intersection of science, business, and public health.

Other Principals or Insiders of the Resulting Issuer

The following are different Principals or Insiders (as these phrases are outlined in TSXV insurance policies) presently contemplated in reference to the Resulting Issuer. If any additional Principals or Insiders are proposed in reference to the Resulting Issuer, such different individuals will probably be disclosed in a subsequent press release of AAJ. Certain common shares of the Resulting Issuer to be issued pursuant to the Proposed Transaction are anticipated to be subject to restrictions on resale or escrow underneath the insurance policies of the TSXV, together with the securities to be issued to Principals, which will probably be subject to the escrow necessities of the Exchange.

XRP Healthcare M&A Holding Inc.

XRP Healthcare M&A Holding Inc. (“XRP”) is a privately held company integrated in Abu Dhabi, United Arab Emirates, targeted on modernizing healthcare entry throughout rising markets. Through strategic acquisitions and proprietary point-of-care diagnostics, the company operates a growing pharmacy and wholesale distribution community and goals to scale built-in health companies throughout Africa. XRP additionally leverages its AI-powered digital platform, XRPH AI, to boost affected person engagement, ship multilingual healthcare help, and improve health outcomes throughout the areas it serves. The company operates by means of its 90%-owned subsidiary in Uganda. XRP Healthcare M&A Holding Inc. was integrated in February 19^th, 2025, that holds 90% of the PharmaVille Shares. The shareholders of XRP are Kain Roomes (holding 50%), and Laban Roomes (holding 50%).

Pharma Ville Limited

Pharma Ville Limited integrated in 2016, Pharma Ville is a well-established pharmaceutical company headquartered in Kampala, Uganda, working a whole of seven branches—together with 5 wholesale distribution facilities and two retail pharmacies.  Its wholesale operations provide a broad vary of pharmaceutical merchandise to hospitals, clinics, and pharmacies all through the area, whereas its shops serve native communities with accessible prescription and over-the-counter drugs. Known for its regulatory compliance, skilled workforce, and market presence, Pharma Ville represents a sturdy platform for growth within the area.  As half of its integration into XRP Healthcare’s increasing community, Pharma Ville is anticipated to benefit from enhanced operational systems and alignment with the company’s AI-powered healthcare initiatives—supporting effectivity, data-driven insights, and improved affected person outcomes. The shareholders of Pharma Ville are XRP Healthcare Holding Inc. (holding 90%), Richard Kitaka Kitonsa (holding 5%), and Ssegawa Rebecca Nabasirye (holding 5%).

Sponsorship of the Proposed Transaction

As disclosed within the LOI Press Release, AAJ and XRP collectively intends to make an software for waiver from the sponsorship necessities of the TSXV in reference to the Proposed Transaction; nonetheless, there’s no assurance that the TSXV will waive all or half of relevant sponsorship necessities.

Trading Halt

As disclosed within the LOI Press Release, in accordance with the insurance policies of the TSXV, trading within the AAJ Shares has been halted and isn’t anticipated to renew trading till completion of the Proposed Transaction or till the TSXV receives the requisite documentation to renew trading.

AAJ Meeting

As the Proposed Transaction is just not a “Non-Arm’s Length Qualifying Transaction” (within the that means of Policy 2.4 of the Exchange), it isn’t anticipated that the Proposed Transaction will require approval of the AAJ Shareholders. However, the Name Change, the Resulting Issuer director appointments and the implementation of an equity incentive plan for the Resulting Issuer will require the approval of AAJ Shareholders at an annual and particular assembly of AAJ Shareholders (the “AAJ Meeting“) that’s anticipated to be held previous to the completion of the Proposed Transaction. Further particulars with respect to the issues to be accredited on the AAJ Meeting will probably be contained within the management info round ready in reference to AAJ Meeting and obtainable for review on AAJ’s SEDAR+ profile at www.sedarplus.ca.

Advisors

ARC Group Limited is performing because the unique financial advisor to XRP Healthcare M&A Holding Inc Oakridge Law LLP (Ontario) is serving as legal counsel to XRP Healthcare M&A Holding Inc.

Additional Information

Additional info regarding the Proposed Transaction and any related transactions of AAJ, XRP and the Resulting Issuer, will probably be supplied in subsequent press releases and in AAJ’s management info round or prospectus to be ready in reference to the Proposed Transaction, to be filed in reference to the Proposed Transaction, which will probably be obtainable underneath AAJ’s SEDAR+ profile at www.sedarplus.ca.

All info contained on this press release with respect to AAJ and XRP was provided by or from the respective get together for inclusion herein, with out unbiased review by the opposite get together, and every get together and its administrators and officers have relied on the opposite get together for any info regarding the different get together.

Completion of the Proposed Transaction is subject to a quantity of situations, together with however not restricted to, Exchange acceptance and, if relevant pursuant to Exchange necessities, majority of the minority shareholder approval. Where relevant, the Proposed Transaction can not close till the required shareholder approval is obtained. There may be no assurance that the Proposed Transaction will probably be accomplished as proposed or in any respect.

Investors are cautioned that, besides as disclosed within the management info round or itemizing assertion to be ready in reference to the Proposed Transaction, any info launched or acquired with respect to the Proposed Transaction is probably not correct or full and shouldn’t be relied upon. Trading within the securities of a capital pool company needs to be thought-about extremely speculative.

The TSX Venture Exchange Inc. has in no method handed upon the deserves of the Proposed Transaction and has neither accredited nor disapproved the contents of this press release.

Further Information

For additional info, please contact:

AAJ Capital 3 Corp.
Peeyush Varshney, CEO
Email:  peeyush@varshneycapital.com 
Phone: 604-684-2181
XRP Healthcare M&A Holding Inc.
Kain Roomes
Email: kain@xrphealthcare.com
Phone: +44 7545 026879

Forward-Looking Information

This press release accommodates forward-looking statements and forward-looking info (collectively, “forward-looking statements“) within the meaning of applicable securities laws. Any statements that are contained in this press release that are not statements of historical fact may be deemed to be forward-looking statements. Forward-looking statements are often identified by terms such as “may”, “should”, “anticipate”, “will”, “estimates”, “believes”, “intends” “expects” and comparable expressions that are meant to determine forward-looking statements. More significantly and with out limitation, this press release accommodates forward-looking statements regarding the Proposed Transaction, the Name Change, the AAJ Meeting, the Private Placement, the anticipated composition of the board of administrators and senior officers of the Resulting Issuer, the completion and timing of the applying to the TSXV in respect of the Proposed Transaction, the proposed construction by which the Proposed Transaction is to be accomplished, the flexibility of AAJ and XRP to fulfill the situations of the Proposed Transaction within the required timeframes, the obtainment of the mandatory exemptions and approvals from the TSXV or different regulatory our bodies, subsequent press releases and the business, identify and performance of the Resulting Issuer and sure financial info and forecasts.

AAJ cautions that each one forward-looking statements are inherently unsure, and that precise efficiency could also be affected by a quantity of materials components, assumptions and expectations, many of that are past the control of AAJ and XRP, together with expectations and assumptions regarding AAJ, XRP, the Resulting Issuer, the Proposed Transaction, the closing of the Proposed Transaction, the well timed receipt of all required shareholder and regulatory approvals, together with the acceptance of the TSXV, the satisfaction of different closing situations in accordance with the phrases of the Definitive Agreement, in addition to different dangers, uncertainties and assumptions, together with assumptions relating to prevailing market situations and common business, financial, aggressive, political and social uncertainties to develop the forward-looking info on this press release. There may be no assurance that such statements, though thought-about affordable by management on the time of preparation, will show to be correct, as precise outcomes and future occasions may differ materially from these anticipated in such statements. Accordingly, the reader is cautioned to not place undue reliance on any forward-looking statements. Forward-looking statements contained on this press release are expressly certified by this cautionary assertion.

The forward-looking statements contained on this press release are made as of the date of this press release, and AAJ doesn’t undertake any obligation to replace publicly or to revise any of the included forward-looking statements, whether or not as a consequence of new info, future occasions or in any other case, besides as expressly required by securities law.

This press release shall not represent an offer to sell or the solicitation of an offer to buy any securities in any jurisdiction.

Neither TSXV nor its Regulation Services Provider (as that time period is outlined within the insurance policies of the TSX Venture Exchange) accepts accountability for the adequacy or accuracy of this press release.

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES.

Photo – https://mma.prnewswire.com/media/2732663/XRP_Healthcare.jpg
Logo – https://mma.prnewswire.com/media/2365357/5418341/XRP_Healthcare_Logo.jpg

View unique content material:(*3*)https://www.prnewswire.co.uk/news-releases/aaj-capital-3-corp-announces-definitive-agreement-for-qualifying-transaction-with-xrp-healthcare-ma-holding-inc-302507061.html

Featured Image: depositphotos @ akulamatiau

Disclaimer